CIK 0000784199 · Large accelerated filer
ARTIVION, INC.
Sign in to watch- Ticker
- AORT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 592417093
- Phone
- 7704193355
- Business address
- 1655 ROBERTS BOULEVARD N W, KENNESAW, GA, 30144
- Former names
- CRYOLIFE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,529,843
- in 3 filings
Net −$2,529,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-24 | Horton Amy VP, Chief Accounting Officer | Sale | −1,706 | $27.31 | $47K | 132,758 |
| 2025-02-24 | Horton Amy VP, Chief Accounting Officer | Sale | −814 | $27.31 | $22K | 131,944 |
| 2025-02-24 | Horton Amy VP, Chief Accounting Officer | Sale | −318 | $27.31 | $9K | 131,626 |
| 2025-02-24 | Horton Amy VP, Chief Accounting Officer | Sale | −485 | $27.31 | $13K | 131,141 |
| 2025-02-24 | Mackin James P President & CEO | Sale | −16,664 | $27.31 | $455K | 689,374 |
| 2025-02-24 | Mackin James P President & CEO | Sale | −13,784 | $27.31 | $376K | 675,590 |
| 2025-02-24 | Mackin James P President & CEO | Sale | −6,812 | $27.31 | $186K | 668,778 |
| 2025-02-24 | Mackin James P President & CEO | Sale | −4,896 | $27.31 | $134K | 663,882 |
| 2025-02-24 | Holloway Jean F SVP, General Counsel | Sale | −2,385 | $27.31 | $65K | 152,749 |
| 2025-02-24 | Holloway Jean F SVP, General Counsel | Sale | −490 | $27.31 | $13K | 152,259 |
| 2025-02-24 | Holloway Jean F SVP, General Counsel | Sale | −810 | $27.31 | $22K | 151,449 |
| 2025-02-24 | Holloway Jean F SVP, General Counsel | Sale | −1,650 | $27.31 | $45K | 149,799 |
| 2025-02-24 | Davis John E Chief Commercial Officer | Sale | −2,846 | $27.31 | $78K | 164,242 |
| 2025-02-24 | Davis John E Chief Commercial Officer | Sale | −591 | $27.31 | $16K | 163,651 |
| 2025-02-24 | Davis John E Chief Commercial Officer | Sale | −985 | $27.31 | $27K | 162,666 |
| 2025-02-24 | Davis John E Chief Commercial Officer | Sale | −2,035 | $27.31 | $56K | 160,631 |
| 2025-02-24 | Berry Lance A Executive VP, CFO | Sale | −3,259 | $27.31 | $89K | 75,805 |
| 2025-02-24 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −2,299 | $27.31 | $63K | 82,233 |
| 2025-02-24 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −470 | $27.31 | $13K | 81,763 |
| 2025-02-24 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −672 | $27.31 | $18K | 81,091 |
Page 10 of 11 · 201 trades